Movifast (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution)

100 ml bottle: ৳ 160.00

Medicine Details

Category Details
Generic Polyethylene glycol 3350 electrolytes
Company Ziska pharmaceuticals ltd
Also available as
Movifast 13125 gm powder

Indications

  • Effective relief from constipation in adults and children over 12 years of age
  • Treatment of chronic constipation
  • Effective in resolving fecal impaction

Composition

  • Each 25 ml concentrated oral solution contains Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, and Potassium Chloride
  • Each sachet (Powder for Suspension) contains Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, and Potassium Chloride

Pharmacology

  • Macrogol (polyethylene glycol) exerts an osmotic action in the gut
  • Increases stool volume triggering colon motility
  • Facilitates defecation
  • Electrolytes combined with Macrogol are exchanged across the intestinal barrier

Dosage & Administration

  • Adults and children aged 12 years and above can take 1 sachet daily for constipation
  • For fecal impaction, 8 sachets daily may be required
  • No dosage change necessary for patients with renal insufficiency
  • Sachets should be dissolved in water as per directions
  • For oral solution, 25 ml added to 100 ml of water once daily for constipation
  • For fecal impaction, 8 doses of 25 ml daily may be required
  • Direction of use for oral solution as per instructions

Interaction

  • Absorption of other medicinal products could be transiently reduced during use with Movifast
  • Isolated reports of decreased efficacy with some concomitantly administered medicinal products

Contraindications

  • Intestinal perforation or obstruction
  • Ileus
  • Severe inflammatory conditions of the intestinal tract
  • Toxic megacolon
  • Hypersensitivity to the active substances

Side Effects

  • Allergic reactions
  • Electrolyte disturbances (hyperkalaemia and hypokalaemia)
  • Abdominal pain
  • Diarrhea
  • Headache
  • Peripheral edema

Pregnancy & Lactation

  • No anticipated effects during pregnancy
  • Can be used during pregnancy
  • No anticipated effects on the breastfed newborn/infant
  • Can be used during breastfeeding

Precautions & Warnings

  • Dosage should be divided for patients with impaired cardiovascular function
  • Symptoms indicating shifts of fluid/electrolytes should be monitored
  • Prolonged use with all laxatives is undesirable
  • May lead to dependence

Overdose Effects

  • Severe pain or distention can be treated by nasogastric aspiration
  • Correction of electrolyte disturbances may be required for extensive fluid loss

Therapeutic Class

  • Osmotic purgatives

Storage Conditions

  • Store below 30°C
  • Place protected from light
  • Do not refrigerate

Related Brands